<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs001544.v1.p1" parentStudy="phs001544.v1.p1" createDate="2018-02-13" modDate="2020-03-17">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>J. Gustav Smith, MD, PhD</td><td>Department of Cardiology, Clinical Sciences, Lund University and Sk&#229;ne University Hospital, Lund, Sweden</td></tr>
		<tr><td>Co-Investigator</td><td>Peter Nilsson, MD, PhD</td><td>Department of Clinical Sciences, Lund University and Sk&#229;ne University Hospital, Malm&#246;, Sweden</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NHLBI TOPMed - NHGRI CCDG: Malmo Preventive Project (MPP)</StudyNameEntrez>
	<StudyNameReportPage>NHLBI TOPMed - NHGRI CCDG: Malmo Preventive Project (MPP)</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Malm&#246; Preventive Project (MPP) was a community-based disease prevention program including 33,346 inhabitants from the city of Malm&#246; in Southern Sweden. Complete birth cohorts between 1921-1949 were invited, and the participation rate was 71%. Participants underwent screening between 1974 to 1992 for cardiovascular risk factors, alcohol abuse, and breast cancer. Between 2002-2006, surviving participants were invited to a reexamination which included blood sampling from which DNA has been extracted. Subjects with prevalent or incident AF were identified from national registers as previously described, and cases with DNA were then matched in a 1:1 fashion to controls with DNA from the same cohort by sex, age (&#177;1 year), and date of baseline exam (&#177;1 year). Also, controls required a follow-up exceeding that of the corresponding AF case.</p>]]>
	</Description>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="19020324"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19936945"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Atrial Fibrillation"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>J. Gustav Smith, MD, PhD</AttName>
			<Institution>Department of Cardiology, Clinical Sciences, Lund University and Sk&#229;ne University Hospital, Lund, Sweden</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Peter Nilsson, MD, PhD</AttName>
			<Institution>Department of Clinical Sciences, Lund University and Sk&#229;ne University Hospital, Malm&#246;, Sweden</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HMB-NPU-MDS" longName="Health/Medical/Biomedical (NPU, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone/>
      <DacUrl/>
    </DacInfo>
    <Policy Policy_ID="phs001544.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001544.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001544.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Health/Medical/Biomedical (NPU, MDS)</ConsentName>
        <ConsentAbbrev>HMB-NPU-MDS</ConsentAbbrev>
        <UseLimitation>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).
Use of the data must be for studies in adults 18 years and older.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd008024.1" type="protocol" createDate="2019-09-25" modDate="2020-03-17" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd008024.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs001544.v1.p1&amp;phd=8024">
      <OrigName>TOPMed_WGS_Methods_Freeze8.docx</OrigName>
      <DisplayName>TOPMed Whole Genome Sequencing Methods: Freeze 8</DisplayName>
      <Description>TOPMed Whole Genome Sequencing Methods: Freeze 8</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>



</Study>

</Studies>

</GaPExchange>
